Advanced Cell Tecnology

What is Astellas Pharma, the purchaser of Ocata?

Fish-eating-fish

Astellas Pharma is on track to purchase Ocata Therapeutics (formerly Advanced Cell Technology). This has stirred a lot of strong feelings amongst investors in Ocata. (Update, now almost 5 years later, the Ocata vision program is still not going full steam ahead at its new owner it seems). I’ve also been wondering what exactly is …

What is Astellas Pharma, the purchaser of Ocata? Read More »

Diverse Stem Cell Person of the Year 2014 Award Finalists

Stem-Cell-Award-Poll-2014

With more than 4,142 votes cast, the readers of this blog have chosen the top 12 finalists for the Stem Cell Person of the Year Award for 2014 from the 27 nominees. You can see the final vote tallies at left. The votes came from more than 50 countries with some interesting geographic patterns (I …

Diverse Stem Cell Person of the Year 2014 Award Finalists Read More »

ACT reinventing itself with new name Ocata Therapeutics

advanced-cell-technology

Here is a link to the Ocata website, marking the start of a new era for what was formerly Advanced Cell Technology or ACT. It’s been a big summer for stem cell biotech Advanced Cell Technology (ACT; stock ACTCD) as it continues what I would call a process of reinventing itself. What’s been happening? ACT recently …

ACT reinventing itself with new name Ocata Therapeutics Read More »

ACT’s Bob Lanza Does the #IceBucketChallenge

Robert-Lanza

Before I did the #icebucketchallenge, I challenged the leader of Advanced Cell Technology (ACT), Dr. Bob Lanza, to do the Ice Bucket Challenge. He did it and leading up to it he provided a quite articulate message for context (see video below). Bob is one very cool guy even without ice water. The purpose of the …

ACT’s Bob Lanza Does the #IceBucketChallenge Read More »

Interview with Robert Klein on CIRM’s Future

What does the future hold for CIRM? I asked former CIRM Board Chair and Prop 71 leader, Robert Klein, about that and more in the interview below. He also says some particularly exciting clinical trial and other developments in the stem cell field are coming soon. What got you excited for the very first time …

Interview with Robert Klein on CIRM’s Future Read More »

Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million

Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding from investment company, Lincoln Park Capital. The press release quotes CEO Gary Rabin: “We are most pleased about this financing agreement, as it has a number of notable benefits for the company,” commented Gary Rabin, chairman and CEO of …

Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million Read More »

Advanced Cell Technology and Geron: allies or competitors?

Geron-300x2212

Two companies, Advanced Cell Technology (ACT) and Geron, both HQ’d here in California, have FDA-approved early stage clinical trials in the works. Geron’s trial has already started and reportedly now has enrolled at least two patients. The trial is of course for the safety of Geron’s GRNOPC1 oligodendrocyte product made from human ES cells for …

Advanced Cell Technology and Geron: allies or competitors? Read More »

Challenges translating stem cell treatments to patients

Geron-300x2212

It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and Advanced Cell Technology (ACT) receiving the OK from the FDA to proceed with initial clinical trials of stem cell treatments. It’s OK to be excited about the clinical trials and I for one am, but we have to …

Challenges translating stem cell treatments to patients Read More »